Camille L Bedrosian Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity

Camille L Bedrosian is of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 9,400 shares of CRNX, which is worth approximately $526,964. The most recent transaction as insider was on Jun 07, 2024, when has been sold 3,400 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.4K

0% 3M change

56.67% 12M change

Total Value Held $526,964

Camille L Bedrosian Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 07 2024	BUY Grant, award, or other acquisition	-	3,400 Added 26.56%	9,400 Common Stock
Jun 16 2023	BUY Grant, award, or other acquisition	-	6,000 Added 50.0%	6,000 Common Stock

Also insider at

RARE

Ultragenyx Pharmaceutical Inc. Healthcare

EVP and Chief Medical Officer

RYTM

RHYTHM PHARMACEUTICALS, INC. Healthcare

Director

AMLX

Amylyx Pharmaceuticals, Inc. Healthcare

Chief Medical Officer

CLB